Novo Nordisk invests billions of dollars in post-semaglutide future

In the coming years, Novo Nordisk will increase its R&D costs at a higher rate than future top line growth to find one or more successors for the current growth engine semaglutide once its patent expires. Although Novo’s faith in its scientists is strong, external acquisitions remain an option, says CFO Karsten Munk Knudsen.

Karsten Munk Knudsen, CFO at Novo Nordisk | Photo: Novo Nordisk / PR

Novo Nordisk has been riding a wave of success in recent years, due in large part to GLP 1 analog semaglutide – but now is not the time to slack off on the work to bring new drugs to market, says Novo Nordisk’s CFO, Karsten Munk Knudsen at a teleconference on Wednesday in connection with the release of Novo’s 2021 financial figures.

”The way it works in the pharmaceutical industry is that you have to have innovation when you are benefitting strongly from sales of your products, so there are products ready to take over once the oldest products begin to sell less,” the CFO said.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Rumored GN purchase unlikely but not impossible, say analysts

A low value assessment, a high structural value, and no dominant shareholders make GN Group a reasonable investment case for international private equity firms and industrial players. But just how likely is it? Analysts reveal their best bets for what a GN acquisition could look like.

New CFO wants to shake things up at WSA

A mere month into her new job, Marianne Wiinholt, WS Audiology’s fifth chief financial officer since the firm was established through a merger in 2019, is heralding great structural changes.

Further reading

Related articles

Latest news

See all jobs